Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Olanzapine Versus Placebo for Moderately Emetogenic Chemotherapy — Stella

Home/Chemotherapy Induced Nausea and Vomiting/

View on ClinicalTrials.gov

Recruiting

Back to Chemotherapy Induced Nausea and Vomiting trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Thailand

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Bangkok

Key details

Phase

Large-scale testing

Sponsor

Mahidol University

Enrollment target

~140 participants

Started

January 2025

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.